Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
8h
The Montgomery Advertiser on MSNAlabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...
11h
The New Times on MSNRwanda: Journalists Trained in Ethical Reporting to Boost HIV/Aids AwarenessAccurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.
2h
The Punch on MSNUSAID cuts causing ‘catastrophic harm’ doctors tell TrumpHundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...
23h
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...
Allies for Health + Wellbeing, formerly the Pittsburgh AIDS Task Force, is marking 40 years of service in 2025 with a birthday bash, celebrating the 2025 ...
The U.S. embargo continues to hinder Cuba’s healthcare system by restricting access to essential medicines, medical equipment ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results